These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7594930)

  • 1. Effect of blister calendar packs in enhancing compliance with MDT; the Kaduna State (Nigeria) experience.
    Awofeso N; Lammers H; Verschuuren M
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):453-4. PubMed ID: 7594930
    [No Abstract]   [Full Text] [Related]  

  • 2. Blister calendar packs--potential for improvement in the supply and utilization of multiple drug therapy in leprosy control programs.
    Georgiev GD; McDougall AC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):603-10. PubMed ID: 3221116
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience of multidrug therapy blister-calendar packs in an urban leprosy control programme in Bombay.
    Revankar CR; Dhamale CB; Ganapati R
    Lepr Rev; 1991 Sep; 62(3):336. PubMed ID: 1795592
    [No Abstract]   [Full Text] [Related]  

  • 4. Blister calendar packs for the implementation of multiple drug therapy in DANIDA-assisted leprosy control projects in India. Danish International Development Agency.
    Georgiev GD; Kielstrup RW
    Lepr Rev; 1987 Sep; 58(3):249-55. PubMed ID: 3669863
    [No Abstract]   [Full Text] [Related]  

  • 5. Life after multidrug therapy: the managerial implications in leprosy control in Kaduna State, Nigeria.
    Awofeso N
    Trop Doct; 1997 Oct; 27(4):196-8. PubMed ID: 9316358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of MDT through blister calendar packs in leprosy eradication programmes--a multicentre field study (phase I). Multicentre Study Group.
    Revankar CR; Sorensen BH; Kielstrup RW
    Lepr Rev; 1989 Jun; 60(2):135-8. PubMed ID: 2671561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further observations on MDT blister-calendar packs in vertical leprosy eradication programmes--a multicentre study (phase II).
    Revankar CR; Gupta N; Sorensen BH; Naik SS
    Lepr Rev; 1993 Sep; 64(3):250-4. PubMed ID: 8231604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
    Winsley BE; McDougall AC; Brown KE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
    [No Abstract]   [Full Text] [Related]  

  • 9. Disappointing experiences with blister-calendar packs.
    Lever P
    Lepr Rev; 1993 Jun; 64(2):171. PubMed ID: 8341122
    [No Abstract]   [Full Text] [Related]  

  • 10. Blister calendar packs for the treatment of patients in leprosy control programmes with multiple drug therapy (MDT).
    Revankar CR; Sørensen BH
    Lepr Rev; 1988 Mar; 59(1):84. PubMed ID: 3398681
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: Blister-calendar packs for multiple drug therapy in leprosy.
    McDougall AC
    Lepr Rev; 1995 Mar; 66(1):76-8. PubMed ID: 7731345
    [No Abstract]   [Full Text] [Related]  

  • 12. Uniform MDT (U-MDT) regimen for all leprosy patients--another example of wishful thinking.
    Ji B; Saunderson P
    Lepr Rev; 2003 Mar; 74(1):2-6. PubMed ID: 12669926
    [No Abstract]   [Full Text] [Related]  

  • 13. A study on non-adherence to MDT among leprosy patients.
    Rao PS
    Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calendar (blister) packs for multiple drug therapy in leprosy: an inexpensive, locally-produced version.
    Wiseman LA
    Lepr Rev; 1987 Mar; 58(1):85-7. PubMed ID: 3600149
    [No Abstract]   [Full Text] [Related]  

  • 15. Five-year multiple drug therapy in Bendel State leprosy control service--an overview.
    Majoroh TO
    Afr J Med Med Sci; 1993 Sep; 22(3):29-33. PubMed ID: 7839909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of MDT in the three western regions of Nepal.
    Kalthoff PG
    Lepr Rev; 1986; 57 Suppl 3():106-14. PubMed ID: 3573950
    [No Abstract]   [Full Text] [Related]  

  • 18. An investigation of attitudes, beliefs and behaviour of leprosy patients, family members and PHC workers towards multidrug therapy in Yangzhou and Dongtai Districts of China.
    Chen XS; Ye GY; Jiang C; Li WZ; Bian J; Wang H; Chen W
    Lepr Rev; 1997 Jun; 68(2):155-61. PubMed ID: 9217355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25 years of MDT: a caveat.
    Soutar D
    Lepr Rev; 2004 Dec; 75(4):406. PubMed ID: 15682979
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposal regarding MB MDT.
    Van Brakel WH
    Lepr Rev; 1999 Mar; 70(1):71-3. PubMed ID: 10405548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.